Regency Capital Management Inc.\DE
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1863894
HONOLULU, HI
Position in ZNTL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$143,075
+$74,045 QoQ
Shares Held
29,500
0.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#67
of 114 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Regency Capital Management Inc.\DE holds $4,218,259 across 3 Biotechnology names. ZNTL ranks #3 (3.4% of the industry book) .
All Filings in ZNTL
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,075 | 29,500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $69,030 | 29,500 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $39,825 | 29,500 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $44,545 | 29,500 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $34,220 | 29,500 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $46,905 | 29,500 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $89,385 | 29,500 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $108,560 | 29,500 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $120,655 | 29,500 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $464,920 | 29,500 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $451,470 | 29,800 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $300,900 | 15,000 | Shares | Sole | 2023-11-02 | |
| No filing history on record for this holder in this stock. | ||||||